These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23920016)

  • 1. Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
    Won SY; Schlunk F; Dinkel J; Karatas H; Leung W; Hayakawa K; Lauer A; Steinmetz H; Lo EH; Foerch C; Gupta R
    Stroke; 2013 Oct; 44(10):2883-90. PubMed ID: 23920016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage?
    Tanoue S; Inamasu J; Yamada M; Toyama H; Hirose Y
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):374-80. PubMed ID: 25444028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.
    Schaefer JH; Leung W; Wu L; Van Cott EM; Lok J; Whalen M; van Leyen K; Lauer A; van Ryn J; Lo EH; Foerch C
    J Cereb Blood Flow Metab; 2014 May; 34(5):870-5. PubMed ID: 24549187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.
    Na SY; Mracsko E; van Ryn J; Veltkamp R
    Ann Neurol; 2015 Jul; 78(1):137-41. PubMed ID: 25899749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.
    Zhou W; Schwarting S; Illanes S; Liesz A; Middelhoff M; Zorn M; Bendszus M; Heiland S; van Ryn J; Veltkamp R
    Stroke; 2011 Dec; 42(12):3594-9. PubMed ID: 21998060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.
    Lauer A; Cianchetti FA; Van Cott EM; Schlunk F; Schulz E; Pfeilschifter W; Steinmetz H; Schaffer CB; Lo EH; Foerch C
    Circulation; 2011 Oct; 124(15):1654-62. PubMed ID: 21911784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Adachi T; Hoshino H; Takagi M; Fujioka S;
    Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
    Faust AC; Peterson EJ
    J Emerg Med; 2014 Apr; 46(4):525-9. PubMed ID: 24508114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.
    Schlunk F; Van Cott EM; Hayakawa K; Pfeilschifter W; Lo EH; Foerch C
    Stroke; 2012 Jan; 43(1):246-9. PubMed ID: 21998055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
    Simonsen CZ; Steiner T; Tietze A; Damgaard D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e133-4. PubMed ID: 24103671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.
    Sølbeck S; Nilsson CU; Engström M; Ostrowski SR; Johansson PI
    Scand J Clin Lab Invest; 2014 Oct; 74(7):591-8. PubMed ID: 24909158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage.
    Illanes S; Zhou W; Schwarting S; Heiland S; Veltkamp R
    Stroke; 2011 Jan; 42(1):191-5. PubMed ID: 21127298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
    Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage.
    Foerch C; Arai K; Van Cott EM; van Leyen K; Lo EH
    J Cereb Blood Flow Metab; 2009 May; 29(5):1015-21. PubMed ID: 19319147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of postapproval data for dabigatran.
    Redberg RF
    JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
    Sun L; Zhou W; Ploen R; Zorn M; Veltkamp R
    Thromb Haemost; 2013 Jul; 110(1):153-61. PubMed ID: 23615682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of bleeding with dabigatran in atrial fibrillation.
    Hernandez I; Baik SH; Piñera A; Zhang Y
    JAMA Intern Med; 2015 Jan; 175(1):18-24. PubMed ID: 25365537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran bleed risk with closed head injuries: are we prepared?
    Parra MW; Zucker L; Johnson ES; Gullett D; Avila C; Wichner ZA; Kokaram CR
    J Neurosurg; 2013 Sep; 119(3):760-5. PubMed ID: 23634730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and treatment of major bleeding during anticoagulation].
    Yasaka M; Okada Y
    Rinsho Shinkeigaku; 2013; 53(11):997-9. PubMed ID: 24291858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.